Travere Therapeutics
TVTX
TVTX
121 hedge funds and large institutions have $769M invested in Travere Therapeutics in 2016 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 50 increasing their positions, 41 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
121
Holders Change
-5
Holders Change %
-3.97%
% of All Funds
3.03%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.18%
New
18
Increased
50
Reduced
41
Closed
22
Calls
$20.4M
Puts
$4.14M
Net Calls
+$16.3M
Net Calls Change
-$11.9M
Top Buyers
| 1 |
SCM
Scopia Capital Management
New York
|
+$15.8M |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$12.5M |
| 3 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
+$11.6M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$5.1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.96M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$6.26M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$5.92M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$5.6M |
| 4 |
Morgan Stanley
New York
|
-$4.83M |
| 5 |
IHM
Iguana Healthcare Management
New York
|
-$4.48M |
